EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going

Miguel Muniz, Charles L Loprinzi, Jacob J Orme, Regina M Koch, Ahmed M Mahmoud, Adam M Kase, Irbaz B Riaz, Jack R Andrews, Matthew P Thorpe, Geoffrey B Johnson, Ayse T Kendi, Eugene D Kwon und 4 weitere

Cancer Treatment Reviews · 2024-06 · 127 · 102748

DOI: 10.1016/j.ctrv.2024.102748 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-06. Verfasst von Miguel Muniz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Mayo Clinic, Rochester, MN, US. Electronic address: munizrincon.miguel@mayo.edu. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Mayo Clinic, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsAntigens, SurfaceGlutamate Carboxypeptidase IIHumansMaleProstatic Neoplasms, Castration-ResistantLutetiumRadioisotopesSalivary GlandsDipeptidesHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

Dry mouthMetastatic castration-resistant prostate cancer (mCRPC)PSMA-targeted radiopharmaceuticalsSalivary toxicityXerostomia

Substanzen

RadiopharmaceuticalsAntigens, SurfaceGlutamate Carboxypeptidase IILutetiumRadioisotopesDipeptidesHeterocyclic Compounds, 1-RingFOLH1 protein, humanLutetium-177

Autor:innen und Institutionen

  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, US. Electronic address: munizrincon.miguel@mayo.edu.
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, US. Electronic address: cloprinzi@mayo.edu.
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, US. Electronic address: orme.jacob@mayo.edu.
  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, US. Electronic address: koch.regina@mayo.edu.
  • Department of Urology, Mayo Clinic, Rochester, MN, US. Electronic address: mahmoud.ahmed@mayo.edu.
  • Department of Medical Oncology, Mayo Clinic, Jacksonville FL, US. Electronic address: kase.adam@mayo.edu.

Förderung

  • NCATS NIH HHS
  • Mayo Clinic
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Muniz, M., Loprinzi, C. L., Orme, J. J., Koch, R. M., Mahmoud, A. M., Kase, A. M., Riaz, I. B., Andrews, J. R., Thorpe, M. P., Johnson, G. B., Kendi, A. T., Kwon, E. D., Nauseef, J. T., Morgans, A. K., Sartor, O., & Childs, D. S. (2024). Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going. Cancer Treatment Reviews, 127, 102748. https://doi.org/10.1016/j.ctrv.2024.102748

Vancouver

Muniz M, Loprinzi CL, Orme JJ, Koch RM, Mahmoud AM, Kase AM, et al. Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going. Cancer Treatment Reviews. 2024;127:102748. doi:10.1016/j.ctrv.2024.102748

BibTeX
@article{Muniz2024,
  author = {Muniz, Miguel and Loprinzi, Charles L and Orme, Jacob J and Koch, Regina M and Mahmoud, Ahmed M and Kase, Adam M and Riaz, Irbaz B and Andrews, Jack R and Thorpe, Matthew P and Johnson, Geoffrey B and Kendi, Ayse T and Kwon, Eugene D and Nauseef, Jones T and Morgans, Alicia K and Sartor, Oliver and Childs, Daniel S},
  title = {Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {127},
  pages = {102748},
  doi = {10.1016/j.ctrv.2024.102748}
}
Kostenlos starten →